IDEAS home Printed from https://ideas.repec.org/r/wly/hlthec/v13y2004i8p749-765.html
   My bibliography  Save this item

Comparing alternative models: log vs Cox proportional hazard?

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Jones, A. & Lomas, J. & Rice, N., 2014. "Going Beyond the Mean in Healthcare Cost Regressions: a Comparison of Methods for Estimating the Full Conditional Distribution," Health, Econometrics and Data Group (HEDG) Working Papers 14/26, HEDG, c/o Department of Economics, University of York.
  2. Noémi Kreif & Richard Grieve & M. Zia Sadique, 2013. "Statistical Methods For Cost‐Effectiveness Analyses That Use Observational Data: A Critical Appraisal Tool And Review Of Current Practice," Health Economics, John Wiley & Sons, Ltd., vol. 22(4), pages 486-500, April.
  3. Thompson, Simon G. & Nixon, Richard M. & Grieve, Richard, 2006. "Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study," Journal of Health Economics, Elsevier, vol. 25(6), pages 1015-1028, November.
  4. Andrei Barbos & Yi Deng, 2015. "The Impact Of A Public Option In The U.S. Health Insurance Market," Economic Inquiry, Western Economic Association International, vol. 53(1), pages 508-521, January.
  5. Joseph F. Levy & Marjorie A. Rosenberg, 2019. "A Latent Class Approach to Modeling Trajectories of Health Care Cost in Pediatric Cystic Fibrosis," Medical Decision Making, , vol. 39(5), pages 593-604, July.
  6. Adam Gorajek, 2019. "The Well-meaning Economist," RBA Research Discussion Papers rdp2019-08, Reserve Bank of Australia.
  7. Gaskin, Darrell J. & Zare, Hossein & Delarmente, Benjo A., 2021. "Geographic disparities in COVID-19 infections and deaths: The role of transportation," Transport Policy, Elsevier, vol. 102(C), pages 35-46.
  8. Greta Lozano-Ortega & Carol R. Schermer & David R. Walker & Shelagh M. Szabo & Basia Rogula & Alison M. Deighton & Katherine L. Gooch & Noll L. Campbell, 2021. "Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder," PharmacoEconomics - Open, Springer, vol. 5(1), pages 45-55, March.
  9. Manos Matsaganis & Theodore Mitrakos & Panos Tsakloglou, 2009. "Modelling health expenditure at the household level in Greece," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(3), pages 329-336, July.
  10. Andrew M. Jones & James Lomas & Peter T. Moore & Nigel Rice, 2016. "A quasi-Monte-Carlo comparison of parametric and semiparametric regression methods for heavy-tailed and non-normal data: an application to healthcare costs," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 179(4), pages 951-974, October.
  11. Kasteridis, Panagiotis & Rice, Nigel & Santos, Rita, 2022. "Heterogeneity in end of life health care expenditure trajectory profiles," Journal of Economic Behavior & Organization, Elsevier, vol. 204(C), pages 221-251.
  12. Basu A & Manning WG, 2009. "Estimating Lifetime or Episode-of-illness Costs," Health, Econometrics and Data Group (HEDG) Working Papers 09/12, HEDG, c/o Department of Economics, University of York.
  13. Seung Ju Kim & Sun Jung Kim & Kyu-Tae Han & Eun-Cheol Park, 2017. "Medical costs, Cesarean delivery rates, and length of stay in specialty hospitals vs. non-specialty hospitals in South Korea," PLOS ONE, Public Library of Science, vol. 12(11), pages 1-11, November.
  14. Jones, A.M, 2010. "Models For Health Care," Health, Econometrics and Data Group (HEDG) Working Papers 10/01, HEDG, c/o Department of Economics, University of York.
  15. Amal Malehi & Fatemeh Pourmotahari & Kambiz Angali, 2015. "Statistical models for the analysis of skewed healthcare cost data: a simulation study," Health Economics Review, Springer, vol. 5(1), pages 1-16, December.
  16. Megan Hagiwara & Deborah Taira Juarez & Seiji Yamada & Jill Miyamura & Tetine Sentell, 2015. "Inpatient Hospitalization Costs: A Comparative Study of Micronesians, Native Hawaiians, Japanese, and Whites in Hawai‘i," IJERPH, MDPI, vol. 13(1), pages 1-15, December.
  17. Andrew M. Jones & James Lomas & Nigel Rice, 2014. "Applying Beta‐Type Size Distributions To Healthcare Cost Regressions," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 29(4), pages 649-670, June.
  18. Anirban Basu & James J. Heckman & Salvador Navarro-Lozano & Sergio Urzua, 2007. "Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1133-1157.
  19. Vibeke Müller & Ulf Gerdtham & Ann Alriksson‐Schmidt & Johan Jarl, 2022. "Parental decisions to divorce and have additional children among families with children with cerebral palsy: Evidence from Swedish longitudinal and administrative data," Health Economics, John Wiley & Sons, Ltd., vol. 31(10), pages 2170-2186, October.
  20. Yuyun Hidayat & Sukono & Betty Subartini & Nida Khairunnisa & Aceng Sambas & Titi Purwandari, 2022. "An Estimated Analysis of Willingness to Wait Time to Pay Rice Agricultural Insurance Premiums Using Cox’s Proportional Hazards Model," Mathematics, MDPI, vol. 10(21), pages 1-16, October.
  21. Andrew M. Jones & James Lomas & Nigel Rice, 2015. "Healthcare Cost Regressions: Going Beyond the Mean to Estimate the Full Distribution," Health Economics, John Wiley & Sons, Ltd., vol. 24(9), pages 1192-1212, September.
  22. Anirban Basu & James J. Heckman & Salvador Navarro-Lozano & Sergio Urzua, 2007. "Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients," Health, Econometrics and Data Group (HEDG) Working Papers 07/07, HEDG, c/o Department of Economics, University of York.
  23. Mandy Ryan & Emmanouil Mentzakis & Catriona Matheson & Christine Bond, 2020. "Survey modes comparison in contingent valuation: Internet panels and mail surveys," Health Economics, John Wiley & Sons, Ltd., vol. 29(2), pages 234-242, February.
  24. Manning, Willard G. & Basu, Anirban & Mullahy, John, 2005. "Generalized modeling approaches to risk adjustment of skewed outcomes data," Journal of Health Economics, Elsevier, vol. 24(3), pages 465-488, May.
  25. Adam Gorajek, 2022. "Quasilinear‐mean regression," Journal of Economic Surveys, Wiley Blackwell, vol. 36(5), pages 1288-1310, December.
  26. Tatiana Dilla & Amparo Valladares & Claudia Nicolay & Javier Salvador & Jesús Reviriego & María Costi, 2012. "Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain," Applied Health Economics and Health Policy, Springer, vol. 10(6), pages 417-430, November.
  27. Ileana Baldi & Eva Pagano & Paola Berchialla & Alessandro Desideri & Alberto Ferrando & Franco Merletti & Dario Gregori, 2013. "Modeling healthcare costs in simultaneous presence of asymmetry, heteroscedasticity and correlation," Journal of Applied Statistics, Taylor & Francis Journals, vol. 40(2), pages 298-310, February.
  28. Stargardt, Tom & Schreyögg, Jonas, 2012. "A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data," Health Policy, Elsevier, vol. 105(2), pages 110-118.
  29. Anirban Basu & James J. Heckman & Salvador Navarro‐Lozano & Sergio Urzua, 2007. "Use of instrumental variables in the presence of heterogeneity and self‐selection: an application to treatments of breast cancer patients," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1133-1157, November.
  30. Anirban Basu & Bhakti V. Arondekar & Paul J. Rathouz, 2006. "Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity," Health Economics, John Wiley & Sons, Ltd., vol. 15(10), pages 1091-1107, October.
  31. Smith, William C. & Anderson, Emily & Salinas, Daniel & Horvatek, Renata & Baker, David P., 2015. "A meta-analysis of education effects on chronic disease: The causal dynamics of the Population Education Transition Curve," Social Science & Medicine, Elsevier, vol. 127(C), pages 29-40.
  32. Law, Michael R. & Grépin, Karen A., 2010. "Is newer always better? Re-evaluating the benefits of newer pharmaceuticals," Journal of Health Economics, Elsevier, vol. 29(5), pages 743-750, September.
  33. John Mullahy, 2015. "In Memoriam: Willard G. Manning, 1946‐2014," Health Economics, John Wiley & Sons, Ltd., vol. 24(3), pages 253-257, March.
  34. Cici McNamara & Natalia Serna, 2022. "The impact of a national formulary expansion on diabetics," Health Economics, John Wiley & Sons, Ltd., vol. 31(11), pages 2311-2332, November.
  35. Borislava Mihaylova & Andrew Briggs & Anthony O'Hagan & Simon G. Thompson, 2011. "Review of statistical methods for analysing healthcare resources and costs," Health Economics, John Wiley & Sons, Ltd., vol. 20(8), pages 897-916, August.
  36. Manos Matsaganis & Theodore Mitrakos & Panos Tsakloglou, 2008. "Modelling Household Expenditure on Health Care in Greece," Working Papers 68, Bank of Greece.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.